Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Alcoholic Liver Disease: early-phase trial registry
3 of 6 indexed Alcoholic Liver Disease trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 3 currently recruiting · #2,866 of 28,707 conditions by registered trial count
Alcoholic Liver Disease: 6 US clinical trials tracked, 3 recruiting.
Alcoholic Liver Disease is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is The Cleveland Clinic, running 3 of these trials.
Enrollment posture brief
Registry condition alcoholic-liver-disease
OPEN 3 | RECR 50% | LATE 0 | EARLY 1 | RANK #2866 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Achalasia (50% recruiting · 8 trials)
Alcoholic Liver Disease lists 3 open slots (50% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Alcoholic Liver Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Alcoholic Liver Disease is recruiting above its size-band peers.
3 of 6 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Alcoholic Liver Disease research.
The Cleveland Clinic accounts for 3 of 6 trials (50%). 4 distinct sponsors appear on at least one study for this condition label.
-
Most Alcoholic Liver Disease trials plan to enrol fewer than 100 people.
Median target enrolment is 48 among the 6 trials that report a genuine target (sentinel values excluded). 5 of those (83.3%) plan for fewer than 100 participants.
-
Alcoholic Liver Disease splits between interventional and observational designs.
3 interventional and 3 observational studies make up this index (50% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
Evaluating Alcohol Use in Alcoholic Liver Disease
Nicole T Shen
NCT03267069
Study of HMB-enriched Amino Acid Supplementation in Patients With Alcoholic Liver Disease and COVID-19
The Cleveland Clinic
NCT04858412
Ethanol Induces Skeletal Muscle Autophagy
The Cleveland Clinic
NCT03209791
Alcoholic Liver Disease and the Gut Microbiome
University of California, Los Angeles
NCT05007470
Quantitative MRI for Non-invasive Assessment of Severity of Alcoholic Liver Disease (ALD)
The Cleveland Clinic
NCT03113929
A Novel Pharmacotherapy for Alcoholism and Alcohol Liver Disease
Brown University
NCT01504295
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Alcoholic Liver Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Alcoholic Liver Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Alcoholic Liver Disease page
6 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Alcoholic Liver Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- The Cleveland Clinic sponsors the most Alcoholic Liver Disease trials on record, review their full trial history before evaluating a specific study. See The Cleveland Clinic's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Alcoholic Liver Disease condition card totals 6 registered trials; most-linked intervention Metadoxine; top US site state Ohio. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.